SCHEMBL7096431

SCHEMBL7096431

CCc1cc2c(Cl)nc(CCCCCCC(=O)O)nc2s1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.46
ALDH1A1 P00352 4/20 0.46
HSD17B10 Q99714 2/20 0.46
SELE P16581 1/20 0.43
VCAM1 P19320 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
HTT P42858 1/20 0.41
ATM Q13315 1/20 0.40
RAB9A P51151 1/20 0.39
POLB P06746 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
P2RY12 Q9H244 3/20 0.39
LMNA P02545 1/20 0.38
PRNP P04156 1/20 0.38
RECQL P46063 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
PPARA Q07869 1/20 0.38
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7102424 0.99 ALDH1A1 (0.47) KDM4EALDH1A1HSD17B10SELEVCAM1
SCHEMBL7098332 0.90 ALDH1A1 (0.50) KDM4EALDH1A1HSD17B10SELEVCAM1
SCHEMBL6708399 0.86 SELE (0.41) KDM4EALDH1A1HSD17B10SELEVCAM1
SCHEMBL7101124 0.85 F13A1 (0.39) ALDH1A1POLBTDP1LMNAPRNP
SCHEMBL6706662 0.82 SELE (0.42) KDM4EALDH1A1HSD17B10SELEVCAM1
SCHEMBL6706646 0.80 SELE (0.44) KDM4EALDH1A1HSD17B10SELEVCAM1
SCHEMBL31044813 0.77 SELE (0.58) KDM4EALDH1A1HSD17B10SELEVCAM1
SCHEMBL7100819 0.75 CSNK2A2 (0.46) KDM4EALDH1A1HSD17B10MEN1KMT2A
SCHEMBL7100139 0.72 KDM4E (0.48) KDM4EALDH1A1MEN1KMT2AHTT
SCHEMBL6708361 0.71 HPGD (0.38) KDM4EALDH1A1KMT2AP2RY12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1347761-A2 PHARMACEUTICAL FORMULATION CONTAINING THIENOPYRIMIDINES AND ANTITHROMBOTICS, CALCIUM ANTAGONISTS, PROSTAGLANDINS OR PROSTAGLANDIN DERIVATIVES MERCK PATENT GmbH (DE) 2003-10-01 EP disclosed
EP-1337256-A2 USE OF THIENOPYRIMIDINES MERCK PATENT GmbH (DE) 2003-08-27 EP disclosed
WO-2002049650-A2 PHARMACEUTICAL FORMULATION CONTAINING THIENOPYRIMIDINES AND ANTITHROMBOTICS, CALCIUM ANTAGONISTS, PROSTAGLANDINS OR PROSTAGLANDIN DERIVATIVES MERCK PATENT GMBH (DE) 2002-06-27 WO disclosed
WO-2002041896-A2 USE OF THIENOPYRIMIDINES MERCK PATENT GMBH (DE) 2002-05-30 WO disclosed
EP-1036078-A1 THIENOPYRIMIDINES MERCK PATENT GmbH (DE) 2000-09-20 EP disclosed
WO-1999028325-A1 THIENOPYRIMIDINES MERCK PATENT GMBH (DE) 1999-06-10 WO disclosed